These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18824926)

  • 1. Rituximab for severe refractory pediatric Wegener granulomatosis.
    Patel AM; Lehman TJ
    J Clin Rheumatol; 2008 Oct; 14(5):278-80. PubMed ID: 18824926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wegener granulomatosis with massive intracerebral hemorrhage: remission of disease in response to rituximab.
    Memet B; Rudinskaya A; Krebs T; Oelberg D
    J Clin Rheumatol; 2005 Dec; 11(6):314-8. PubMed ID: 16371801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
    Bachmeyer C; Cadranel JF; Demontis R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintaining remission in a patient with vasculitis.
    Flossmann O; Jayne DR
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG; Skopouli FN
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on Wegener granulomatosis.
    Langford CA
    Cleve Clin J Med; 2005 Aug; 72(8):689-90, 693-7. PubMed ID: 16122054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of orbital inflammation with rituximab in Wegener's granulomatosis.
    Baslund B; Wiencke AK; Rasmussen N; Faurschou M; Toft PB
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S7-10. PubMed ID: 22272561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
    Lynch JP; Tazelaar H
    Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab reversed cardiac involvement of Wegener's granulomatosis: magnetic resonance imaging assessment.
    Brihaye B; Aouba A; Pagnoux C; Vignaux O; Le Hello C; Guillevin L
    Presse Med; 2008 Mar; 37(3 Pt 1):412-5. PubMed ID: 18276102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wegener's granulomatosis effectively treated with rituximab: a case study.
    Kowalewska B; Szechiński J; Roszkowska E
    Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab.
    Caetano J; Fernandes das Neves M; Oliveira S; Delgado Alves J
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519869
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab in refractory Wegener's granulomatosis: Favorable or not?
    Aries PM; Lamprecht P; Gross WL
    Am J Respir Crit Care Med; 2006 Apr; 173(7):815-6; author reply 816. PubMed ID: 16556703
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab induced remission in a patient with Wegener's granulomatosis.
    Kallenbach M; Duan H; Ring T
    Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.